SAM
KPTI icon

Sectoral Asset Management’s Karyopharm Therapeutics KPTI Stock Holding History

Sectoral Asset Management’s Portfolio KPTI Stock Details KPTI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-47,531
Closed -$7.51M – 77
2015
Q3 		$7.51M Hold
47,531
– – 0.34% 52
2015
Q2 		$19.4M Buy
47,531
+380
+0.8% +$164K 0.81% 37
2015
Q1 		$21.6M Buy
47,151
+11,823
+33% +$5.1M 0.82% 41
2014
Q4 		$19.8M Buy
35,328
+2,772
+9% +$1.57M 0.89% 38
2014
Q3 		$17.1M Buy
32,556
+14,653
+82% +$8.27M 0.72% 41
2014
Q2 		$12.5M Buy
+17,903
New +$8.33M 0.53% 47
2014
Q1 		– Sell
-2,333
Closed -$802K – 66
2013
Q4 		$802K Buy
+2,333
New +$644K 0.03% 56

Other funds holding KPTI

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Sectoral Asset Management's KPTI Position: Q4 2015 in Review

Sectoral Asset Management sold out of Karyopharm Therapeutics (KPTI) in Q4 2015, closing a stake of 47,531 shares — an estimated $7.51M sold.

Sectoral Asset Management first reported a position in KPTI in Q4 2013 and held it in 7 quarters. The position peaked at $21.6M in Q1 2015. 85 funds tracked by Wall St. Rank hold KPTI as of Q4 2015.

  • Sectoral Asset Management reported no remaining Karyopharm Therapeutics position as of Q4 2015 after selling out during the quarter.
  • Sectoral Asset Management sold 47,531 Karyopharm Therapeutics shares in Q4 2015, an estimated $7.51M.
  • Sectoral Asset Management first reported a position in Karyopharm Therapeutics in Q4 2013 and held it in 7 quarters.
  • Sectoral Asset Management's Karyopharm Therapeutics position peaked at $21.6M in Q1 2015.
  • 85 funds tracked by Wall St. Rank held Karyopharm Therapeutics as of Q4 2015.

Based on Sectoral Asset Management's 13F filing for Q4 2015, filed 12 Feb 2016.